Literature DB >> 29664368

Antimicrobial-Resistant Bacteria in Infected Wounds, Ghana, 20141.

Hauke Janssen, Iryna Janssen, Paul Cooper, Clemens Kainyah, Theresia Pellio, Michael Quintel, Mathieu Monnheimer, Uwe Groß, Marco H Schulze.   

Abstract

Wound infections are an emerging medical problem worldwide, frequently neglected in under-resourced countries. Bacterial culture and antimicrobial drug resistance testing of infected wounds in patients in a rural hospital in Ghana identified no methicillin-resistant Staphylococcus aureus or carbapenem-resistant Enterobacteriaceae but identified high combined resistance of Enterobacteriaceae against third-generation cephalosporins and fluoroquinolones.

Entities:  

Keywords:  AMR; Enterobacteriaceae; Ghana; MRSA; antimicrobial resistance; bacteria; gram-negative bacteria; multiresistant; polymicrobial infections; resistance; rural; wound infections

Mesh:

Substances:

Year:  2018        PMID: 29664368      PMCID: PMC5938797          DOI: 10.3201/eid2405.171506

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Bacteriologic investigation of clinical specimens is an essential tool for active surveillance of antimicrobial drug resistance. Knowledge of causative bacterial species and their resistance profile enables targeted antimicrobial therapy, limits ineffective antimicrobial therapy, and avoids in part unnecessary antimicrobial pressure to noninvolved bacterial pathogens (). Available antimicrobial resistance data will sensitize clinicians and policy makers and are a prerequisite for updating national treatment guidelines (,). These data contribute to prevention and control of antimicrobial drug resistance (). Wound infections are an emerging medical problem worldwide; the economic burden and morbidity and mortality rates are huge (,). Because of the frequent polymicrobial nature of infected wounds, bacteriologic investigations are demanding and frequently neglected in sub-Saharan Africa countries ().

The Study

Since 2000, the Institute for Medical Microbiology of the University Medical Center Goettingen, Goettingen, Germany, has assisted the running of the bacteriology laboratory in St. Martin de Porres Hospital in Eikwe, Ghana (). Eikwe is a rural coastal village in the Western Region of Ghana; its mission hospital has an admission capacity of ≈200 beds and serves ≈380,000 persons. During March–July 2014, we conducted a prospective study at St. Martin de Porres Hospital, performing bacteriologic investigations of infected wounds of inpatients and outpatients during routine working hours (Monday–Friday, 8 am–4 pm). The hospital administration (the local ethics review panel) authorized the study. Patients from whom wound swab samples were investigated provided consent to be included in the study. Medical doctors diagnosed wound infections clinically, according to the classic signs of inflammation. After wounds were carefully cleaned with sterile gauze moistened with a sterile solution of 0.9% sodium chloride, samples were collected from the wound ground and edge on sterile cotton swabs and immediately transported to the bacteriology laboratory in Amies transport medium (Copan, Brescia, Italy). The samples were inoculated onto MacConkey agar and 7% sheep blood agar (Tulip Diagnostics, Goa, India) and thereafter incubated aerobically at 35°C. Both plates were read after 24 and 48 hours. Gram staining was performed to ensure wound specimen quality and to check for bacteria, neutrophils, and epithelial cells. Bacterial isolates were initially identified (to genus level) by colony morphology, Gram staining, catalase reaction, oxidase reaction, coagulase reaction, indole reaction, and growth on Kligler iron agar, as described by Cheesbrough (). Bacterial isolates were stored in microbanks at −20°C. Species identification was completed (to species level) at the Institute for Medical Microbiology in Goettingen, Germany, by using MALDI Biotyper 3.0 (Bruker Daltonics, Bremen, Germany). According to locally available resources, antimicrobial resistance testing was performed through disk diffusion, which guided the treatment of the wound infections. Antimicrobial resistance testing was repeated with VITEK 2 (bioMérieux, Marcy-l’Étoile, France) at the Institute for Medical Microbiology by using AST-P632, AST-P586, AST-N214, and AST-N248 cards with respect to bacterial species and according to the breakpoint tables for interpretation of MICs in EUCAST version 4.0 (). Quality control was performed with the reference strains Pseudomonas aeruginosa ATCC 27853, Escherichia coli ATCC 25922, and Staphylococcus aureus ATCC 29213. Of the 67 wound swab samples, 39 (58.2%) were from female patients. The mean age of the 67 patients was 40.1 ± 20.8 years (range 1–90 years, median 39 years). Of the 67 samples, collection sites were upper extremity for 4 (6.0%), trunk/head for 15 (22.4%), lower extremity for 39 (58.2%), and laparotomy site for 9 (13.4%) (Technical Appendix). A hospital-acquired wound infection was diagnosed for 21 (31.3%) patients. All investigated wound swab samples grew bacterial pathogens. Overall, 32 species of bacteria were isolated; median was 3 (range 1–7) species/specimen. Of the 189 isolated species, 72 (38.1%) were Enterobacteriaceae, 69 (36.5%) were gram positive, and 48 (25.4%) were nonfermenters (Technical Appendix Table 2). Of the 67 samples, infection was monomicrobial in 17 (25.4%) and polymicrobial in 50 (74.6%). The most frequently detected bacterium in monomicrobial and polymicrobial infections was S. aureus. The predominant bacteria in polymicrobial infections were Enterobacteriaceae and nonfermenters (Technical Appendix Table 3). Results of VITEK 2 antimicrobial resistance testing of the most frequently found bacterial species are shown in Table 1.
Table 1

Percentages of antimicrobial drug resistance in selected bacterial species in wound infections, Ghana, 2014*

Drug% Resistant
Staphylococcus aureus, n = 31Enterococcus faecalis, n = 21Proteus mirabilis, n = 20Escherichia coli, n = 19Klebsiella pneumoniae, n = 13Enterobacter cloacae complex, n = 10Pseudomonas aeruginosa, n = 20Acinetobacter. baumannii complex, n = 8
PEN93.5
AMP070.094.7100100
OXA0
SAM045.082.269.2100
TZP010.546.230.010.0
CXM5.057.946.280.0
CTX5.047.446.240.0
CAZ5.047.446.240.05.037.5†
IPM00
MEM00005.00
ERY3.2100
CLI3.2100
TET67.7100
GEN3.215.046.246.240.010.062.5
AMI00
CIP20.046.246.230.015.037.5
LVX0
SXT32.310075.069.269.250.0
FOF0
RIF0
VAN00

*Antimicrobial susceptibility testing was performed with VITEK 2 (bioMérieux, Marcy-l'Étoile, France) according to the EUCAST breakpoint tables for interpretation of MICs, version 4.0, 2014 (). Blank cells indicate no testing performed. AMI, amikacin; AMP, ampicillin; CAZ, ceftazidime; CIP, ciprofloxacin; CLI, clindamycin; CTX, cefotaxime; CXM, cefuroxime; ERY, erythromycin; FOF, fosfomycin; GEN, gentamicin; IPM, imipenem; LVX, levofloxacin; MEM, meropenem; OXA, oxacillin; PEN, penicillin; RIF, rifampin; SAM, ampicillin/sulbactam; SXT, trimethoprim/sulfamethoxazole; TET, tetracycline; TZP, piperacillin/tazobactam; VAN, vancomycin.
†The interpretation of the CAZ MIC for A. baumannii complex followed the recommendations of the Clinical and Laboratory Standards Institute performance standards for antimicrobial susceptibility testing ().

*Antimicrobial susceptibility testing was performed with VITEK 2 (bioMérieux, Marcy-l'Étoile, France) according to the EUCAST breakpoint tables for interpretation of MICs, version 4.0, 2014 (). Blank cells indicate no testing performed. AMI, amikacin; AMP, ampicillin; CAZ, ceftazidime; CIP, ciprofloxacin; CLI, clindamycin; CTX, cefotaxime; CXM, cefuroxime; ERY, erythromycin; FOF, fosfomycin; GEN, gentamicin; IPM, imipenem; LVX, levofloxacin; MEM, meropenem; OXA, oxacillin; PEN, penicillin; RIF, rifampin; SAM, ampicillin/sulbactam; SXT, trimethoprim/sulfamethoxazole; TET, tetracycline; TZP, piperacillin/tazobactam; VAN, vancomycin.
†The interpretation of the CAZ MIC for A. baumannii complex followed the recommendations of the Clinical and Laboratory Standards Institute performance standards for antimicrobial susceptibility testing (). The spectrum of isolated bacteria is comparable to that reported by other studies from sub-Saharan Africa countries, such as Nigeria (), Tanzania (), and Rwanda (). Frequently, studies describe detected pathogens at the genus level only (,). Concerning the proportion of gram-positive to gram-negative pathogens, we isolated slightly more gram-positive pathogens than others (,–). One of the most common bacteria found in wound infections is S. aureus (,,–), which was most frequently identified in our study (Technical Appendix Table 2); however, we detected no methicillin-resistant S. aureus (MRSA). In contrast, studies from urban areas in sub-Saharan Africa countries found MRSA rates of >80% (,). Urban areas are centers of specialized healthcare, where many patients who may already have a long medical history are referred. Such referrals predispose urban patients, staff, and others to more MRSA colonization and infection than experienced by those in rural areas (). The hospital in Eikwe is a general hospital; the villagers are mainly fishermen, and there are no big animal farms in the area. Predisposition to MRSA in this area may be low. We found no carbapenem resistance in Enterobacteriaceae (Table 1). Of great concern were the high rates of resistance of E. coli, Klebsiella pneumoniae, and Enterobacter cloacae complex against third-generation cephalosporins, fluoroquinolones, or both (Table 2), as have been found in other studies from urban areas (,,). The indiscriminate use of antimicrobial drugs contributes to this factor (). Officially, selling antibiotics without prescription is not allowed in Ghana; however, almost every oral antimicrobial drug is available over the counter without any prescription. Eikwe is no exception, although the spectrum of available antimicrobial drugs may be smaller there than in cities. Development of antimicrobial drug resistance may also be enhanced by circulation of counterfeit drugs ().
Table 2

Ratio of percentages of antimicrobial drug resistance against third-generation cephalosporin CTX and the fluoroquinolone CIP in selected Enterobacteriaceae isolated from wound infections, Ghana, 2014*

Drug resistance% Resistant
Proteus mirabilis, n = 20Eshcerichia coli, n = 19Klebsiella pneumoniae, n = 13Enterobacter cloacae complex, n = 10
CTX-S + CIP-S80.042.153.860.0
CTX-S + CIP-R15.010.5NDND
CTX-R + CIP-SND5.3ND10.0
CTX-R + CIP-R5.042.146.230.0

*Antimicrobial susceptibility testing was performed by using VITEK 2 (bioMérieux, Marcy-l'Étoile, France) according to the EUCAST breakpoint tables for interpretation of MICs, version 4.0, 2014 (). CIP, ciprofloxacin; CTX, cefotaxime; ND, not detected; R, resistant; S, susceptible.

*Antimicrobial susceptibility testing was performed by using VITEK 2 (bioMérieux, Marcy-l'Étoile, France) according to the EUCAST breakpoint tables for interpretation of MICs, version 4.0, 2014 (). CIP, ciprofloxacin; CTX, cefotaxime; ND, not detected; R, resistant; S, susceptible. Resistance of E. coli and K. pneumoniae against third-generation cephalosporins probably occurs through production of extended spectrum β-lactamase; in E. cloacae complex, it is probably through AmpC–β-lactamase. However, this statement is only an assumption because we did not perform molecular analyses. In Eikwe, rain falls throughout the year and humidity is almost constant at 70%–90% despite 2 rainfall peaks (May–June and October–November). The effect of seasonality on the incidence of wound infections and the frequency of infection with gram-negative bacteria may not be so pronounced as that found in other studies from sub-Saharan Africa countries with high variations in humidity (). However, because we analyzed only swab samples collected during March–July, the effect of seasonality is difficult to evaluate.

Conclusions

Antimicrobial drug resistance among gram-negative organisms seems to be widespread in Ghana, even among community-onset infections in rural, resource-limited settings, although MRSA was surprisingly absent. Future research efforts should focus on the transmission dynamics and prevention of gram-negative antimicrobial resistance in those settings. Microbiological investigation of the worldwide problem of wound infections should be encouraged in areas of limited resources and might provide a valuable contribution to the surveillance of increasing antimicrobial resistance, especially in Enterobacteriaceae, and for the treatment of affected patients.

Technical Appendix

Sites and modes of acquisition of wound infections, bacterial species detected in monomicrobial and polymicrobial wound infections, sites of wound infection and detected bacterial species among 67 patients, Ghana, 2014.
  12 in total

1.  High prevalence of antimicrobial resistance among common bacterial isolates in a tertiary healthcare facility in Rwanda.

Authors:  Cyprien Ntirenganya; Olivier Manzi; Claude Mambo Muvunyi; Onyema Ogbuagu
Journal:  Am J Trop Med Hyg       Date:  2015-02-02       Impact factor: 2.345

2.  Seasonal variation and risk factors associated with surgical site infection rate in Kano, Nigeria.

Authors:  Emmanuel Nwankwo; Stephen Edino
Journal:  Turk J Med Sci       Date:  2014       Impact factor: 0.973

3.  Patterns of infections, aetiological agents and antimicrobial resistance at a tertiary care hospital in northern Tanzania.

Authors:  Happiness Houka Kumburu; Tolbert Sonda; Blandina Theophil Mmbaga; Michael Alifrangis; Ole Lund; Gibson Kibiki; Frank M Aarestrup
Journal:  Trop Med Int Health       Date:  2017-02-03       Impact factor: 2.622

Review 4.  Antimicrobial drug resistance among clinically relevant bacterial isolates in sub-Saharan Africa: a systematic review.

Authors:  Stije J Leopold; Frank van Leth; Hayalnesh Tarekegn; Constance Schultsz
Journal:  J Antimicrob Chemother       Date:  2014-05-30       Impact factor: 5.790

5.  Antibiotic Resistance: The Need For a Global Strategy.

Authors:  David P Elder; Martin Kuentz; René Holm
Journal:  J Pharm Sci       Date:  2016-07-07       Impact factor: 3.534

6.  Human skin wounds: a major and snowballing threat to public health and the economy.

Authors:  Chandan K Sen; Gayle M Gordillo; Sashwati Roy; Robert Kirsner; Lynn Lambert; Thomas K Hunt; Finn Gottrup; Geoffrey C Gurtner; Michael T Longaker
Journal:  Wound Repair Regen       Date:  2009 Nov-Dec       Impact factor: 3.617

7.  Bacteremia and antimicrobial drug resistance over time, Ghana.

Authors:  Uwe Gross; Sylvarius K Amuzu; Ring de Ciman; Iparkhan Kassimova; Lisa Gross; Wolfgang Rabsch; Ulrike Rosenberg; Marco Schulze; August Stich; Ortrud Zimmermann
Journal:  Emerg Infect Dis       Date:  2011-10       Impact factor: 6.883

Review 8.  Surveillance for antimicrobial drug resistance in under-resourced countries.

Authors:  Guy Vernet; Catherine Mary; Dany M Altmann; Ogobara Doumbo; Susan Morpeth; Zulfiqar A Bhutta; Keith P Klugman
Journal:  Emerg Infect Dis       Date:  2014-03       Impact factor: 6.883

9.  MRSA in Africa: filling the global map of antimicrobial resistance.

Authors:  Matthew E Falagas; Drosos E Karageorgopoulos; John Leptidis; Ioanna P Korbila
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

10.  Predominance of multi-drug resistant bacterial pathogens causing surgical site infections in Muhimbili National Hospital, Tanzania.

Authors:  Joel Manyahi; Mecky I Matee; Mtebe Majigo; Sabrina Moyo; Stephen E Mshana; Eligius F Lyamuya
Journal:  BMC Res Notes       Date:  2014-08-07
View more
  7 in total

1.  Bacterial diversity significantly reduces toward the late stages among filarial lymphedema patients in the Ahanta West District of Ghana: A cross-sectional study.

Authors:  Samuel O Asiedu; Priscilla Kini; Bill C Aglomasa; Emmanuel K A Amewu; Ebenezer Asiedu; Solomon Wireko; Kennedy G Boahen; Afiat Berbudi; Augustina A Sylverken; Alexander Kwarteng
Journal:  Health Sci Rep       Date:  2022-07-20

2.  Epidemiology of Plasmids in Escherichia coli and Klebsiella pneumoniae with Acquired Extended Spectrum Beta-Lactamase Genes Isolated from Chronic Wounds in Ghana.

Authors:  Frederik Pankok; Stefan Taudien; Denise Dekker; Thorsten Thye; Kwabena Oppong; Charity Wiafe Akenten; Maike Lamshöft; Anna Jaeger; Martin Kaase; Simone Scheithauer; Konstantin Tanida; Hagen Frickmann; Jürgen May; Ulrike Loderstädt
Journal:  Antibiotics (Basel)       Date:  2022-05-19

3.  Microbial epidemiology and antimicrobial resistance patterns of wound infection in Ethiopia: a meta-analysis of laboratory-based cross-sectional studies.

Authors:  Mekonnen Sisay; Teshager Worku; Dumessa Edessa
Journal:  BMC Pharmacol Toxicol       Date:  2019-05-30       Impact factor: 2.483

4.  Clonal Clusters, Molecular Resistance Mechanisms and Virulence Factors of Gram-Negative Bacteria Isolated from Chronic Wounds in Ghana.

Authors:  Denise Dekker; Frederik Pankok; Thorsten Thye; Stefan Taudien; Kwabena Oppong; Charity Wiafe Akenten; Maike Lamshöft; Anna Jaeger; Martin Kaase; Simone Scheithauer; Konstantin Tanida; Hagen Frickmann; Jürgen May; Ulrike Loderstädt
Journal:  Antibiotics (Basel)       Date:  2021-03-22

5.  High Prevalence of Carbapenemase-Producing Acinetobacter baumannii in Wound Infections, Ghana, 2017/2018.

Authors:  Mathieu Monnheimer; Paul Cooper; Harold K Amegbletor; Theresia Pellio; Uwe Groß; Yvonne Pfeifer; Marco H Schulze
Journal:  Microorganisms       Date:  2021-03-05

6.  Wounds, Antimicrobial Resistance and Challenges of Implementing a Surveillance System in Myanmar: A Mixed-Methods Study.

Authors:  Win-Pa Sandar; Saw Saw; Ajay M V Kumar; Bienvenu Salim Camara; Myint-Myint Sein
Journal:  Trop Med Infect Dis       Date:  2021-05-18

7.  Wound Management Property of a Hydroethanolic Leaf Extract of Cnestis ferruginea DC.

Authors:  Jibira Yakubu; G A Koffuor; Talent Atsu-Nunyawu; Jeremiah Aboagye; Irene Aasam Aabeinir; Fasilatu Alhassan; Lord Christian Ocran; Philomena Entsie
Journal:  Adv Pharmacol Pharm Sci       Date:  2021-06-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.